J Korean Med Sci.  2007 Feb;22(1):43-47. 10.3346/jkms.2007.22.1.43.

Comparison of Operative Mortality and Complications between Bronchoplastic Lobectomy and Pneumonectomy in Lung Cancer Patients

• Lee ES
• Park SI
• Kim YH
• Bae CH
• Moon HW
• Chun MS
• Kim DK

• KMID: 1713228
• DOI: http://doi.org/10.3346/jkms.2007.22.1.43

Abstract

Bronchoplastic lobectomy is a lung-saving procedure indicated for central tumors, for which the alternative is pneumonectomy. We compared operative mortality and complications between bronchoplastic lobectomy and pneumonectomy in lung cancer patients. From March 1993 through December 2005, 1,461 patients were surgically resected for non-small cell lung cancer, including 73 who underwent bronchoplastic lobectomy and 258 who underwent pneumonectomy. Bronchoplastic lobectomy was performed on any lesion that could be completely resected by this technique, whereas pneumonectomy was only performed on lesions that could not be removed by bronchoplastic lobectomy. Operative deaths occurred in 1 of 73 (1.4%) bronchoplastic lobectomy and 26 of 258 (10.1%) pneumonectomy patients (p=0.014). Major complications occurred in 16 of 73 (21.9%) bronchoplastic lobectomy and 58 of 258 (22.5%) pneumonectomy patients (p=1.0). Bronchoplastic lobectomy has a lower risk of operative mortality than pneumonectomy. Although the complication rates were similar, bronchoplastic lobectomy was associated with improved postoperative cardiopulmonary status and a low prevalence of fatal complications after bronchial anastomosis. These findings indicate that bronchoplastic lobectomy is a valuable alternative to pneumonectomy for anatomically appropriate patients, regardless of underlying cardiopulmonary function.

Keyword

Lung Neoplasms; Thoracic Surgical Procedures; complications; Mortality

MeSH Terms

Retrospective Studies
Postoperative Complications/*epidemiology
*Pneumonectomy/adverse effects/mortality
Middle Aged
Male
Lung Neoplasms/mortality/*surgery
Lung/*surgery
Humans
Female
Aged
Adult
Adolescent

Reference

1. Price-Thomas C. Conservative resection of the bronchial tree. J R Coll Surg Edinb. 1956. 1:169–186.

2. Allison PR. Course of thoracic surgery in Groningen. Ann R Coll Surg. 1954. 25:20–22.

3. Gaissert HA, Mathisen DJ, Moncure AC, Hilgenberg AD, Grillo HC, Wain JC. Survival and function after sleeve lobectomy for lung cancer. J Thorac Cardiovasc Surg. 1996. 111:948–953.

4. Faber LP, Jensik RJ, Kittle CF. Results of sleeve lobectomy for bronchogenic carcinoma in 101 patients. Ann Thorac Surg. 1984. 37:279–285.

5. Faber LP. Sleeve lobectomy. Chest Surg Clin N Am. 1995. 5:233–251.

6. Suen HC, Meyers BF, Guthrie T, Pohl MS, Sundaresan S, Roper CL, Cooper JD, Patterson GA. Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies. Ann Thorac Surg. 1999. 67:1557–1562.

7. Tedder M, Anstadt MP, Tedder SD, Lowe JE. Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy. Ann Thorac Surg. 1992. 54:387–391.

8. Tronc F, Grégoire J, Rouleau J, Deslauriers J. Long-term results of sleeve lobectomy for lung cancer. Eur J Cardiothorac Surg. 2000. 17:550–556.

9. Martin-Ucar AE, Chaudhuri N, Edwards JG, Waller DA. Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery. Eur J Cardiothorac Surg. 2002. 21:601–605.

10. Deslauriers J, Gregoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites of recurrences. Ann Thorac Surg. 2004. 77:1152–1156.

11. Okada M, Yamagishi H, Satake S, Matsuoka H, Miyamoto Y, Yoshimura M, Tsubota N. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg. 2000. 119:814–819.

12. Mehran RJ, Deslauriers J, Piraux M, Beaulieu M, Guimont C, Brisson J. Survival related to nodal status after sleeve resection for lung cancer. J Thorac Cardiovasc Surg. 1994. 107:576–583.

13. Van Schil PE, Brutel de la Rivière A, Knaepen PJ, van Swieten HA, Reher SW, Goossens DJ, Vanderschueren RG, van den Bosch JM. Long-term survival after bronchial sleeve resection: univariate and multivariate analyses. Ann Thorac Surg. 1996. 61:1087–1091.

14. Icard P, Regnard JF, Guibert L, Magdeleinat P, Jauffret B, Levasseur P. Survival and prognostic factors in patients undergoing parenchymal saving bronchoplastic operation for primary lung cancer: a series of 110 consecutive cases. Eur J Cardiothorac Surg. 1999. 15:426–432.

15. Fadel E, Yildizeli B, Chapelier AR, Dicenta I, Mussot S, Dartevelle PG. Sleeve lobectomy for bronchogenic cancers: factors affecting survival. Ann Thorac Surg. 2002. 74:851–858.

16. Kim YT, Kang CH, Sung SW, Kim JH. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy. Ann Thorac Surg. 2005. 79:1153–1161.

17. Cho SK, Sung KI, Lee C, Lee JI, Kim JH, Kim YT, Sung SW. Long term results of bronchial sleeve resection for primary lung cancer. Korean J Thorac Cardiovasc Surg. 2001. 34:917–923.

18. Terzi A, Lonardoni A, Falezza G, Furlan G, Scanagatta P, Pasini F, Calabro F. Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases. Eur J Cardiothorac Surg. 2002. 21:888–893.

19. Koh YM, Park SJ, Suh GY, Chung MP, Kim H, Kwon OJ, Rhee CH, Kim KM, Kim JG, Shim YM. Preservation of pulmonary function after sleeve lobectomy in patients with lung cancer. Tuberc Respir Dis. 1999. 47:35–41.

20. Burrows B, Harrison RW, Adams WE, Humphreys EM, Long ET, Reimann AF. The postpneumonectomy state: clinical and physiologic observations in thirty-six cases. Am J Med. 1960. 28:281–297.

21. Massard G, Kessler R, Gasser B, Ducrocq X, Elia S, Gouzou S, Wihlm JM. Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer. Eur J Cardiothorac Surg. 1999. 16:276–282.